Olema Pharmaceuticals, Inc. financial data

Symbol
OLMA on Nasdaq
Industry
Pharmaceutical Preparations
Location
780 Brannan Street, San Francisco, CA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 6, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.15K % -8.02%
Debt-to-equity 9.62 % +4.45%
Return On Equity -44.2 % +14.6%
Return On Assets -40.3 % +15%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 57.3M shares +38.5%
Common Stock, Shares, Outstanding 57.2M shares +39.2%
Entity Public Float 245M USD +105%
Common Stock, Value, Issued 4K USD +33.3%
Weighted Average Number of Shares Outstanding, Basic 56.3M shares +38.2%
Weighted Average Number of Shares Outstanding, Diluted 56.3M shares +38.2%

Income Statement

Label TTM Value / Value Unit Change %
Research and Development Expense 104M USD +30.4%
General and Administrative Expense 17.3M USD -19.9%
Operating Income (Loss) -122M USD -19.7%
Nonoperating Income (Expense) 12M USD +175%
Net Income (Loss) Attributable to Parent -110M USD -12.7%
Earnings Per Share, Basic -2.05 USD/shares +14.9%
Earnings Per Share, Diluted -2.05 USD/shares +14.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 16.9M USD -51.7%
Marketable Securities, Current 222M USD +67.7%
Cash, Cash Equivalents, and Short-term Investments 239M USD +42.8%
Assets, Current 242M USD +41.2%
Property, Plant and Equipment, Net 945K USD -25.8%
Operating Lease, Right-of-Use Asset 1.81M USD -6.4%
Other Assets, Noncurrent 16K USD
Assets 255M USD +43.3%
Accounts Payable, Current 4.35M USD +168%
Employee-related Liabilities, Current 396K USD
Liabilities, Current 26.5M USD +78.9%
Operating Lease, Liability, Noncurrent 859K USD -29%
Liabilities 27.4M USD +70.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -118K USD +77.2%
Retained Earnings (Accumulated Deficit) -367M USD -42.6%
Stockholders' Equity Attributable to Parent 227M USD +40.6%
Liabilities and Equity 255M USD +43.3%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -23.5M USD -15.2%
Net Cash Provided by (Used in) Financing Activities 8.82M USD +3910%
Net Cash Provided by (Used in) Investing Activities -20.1M USD -154%
Common Stock, Shares Authorized 490M shares 0%
Common Stock, Shares, Issued 57.3M shares +38.6%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -34.8M USD -302%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 16.9M USD -51.7%
Deferred Tax Assets, Valuation Allowance 71.6M USD +50.9%
Deferred Tax Assets, Gross 71.9M USD +50.4%
Operating Lease, Liability 1.96M USD -2.29%
Payments to Acquire Property, Plant, and Equipment 153K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -109M USD -14.5%
Lessee, Operating Lease, Liability, to be Paid 2.12M USD -4.64%
Property, Plant and Equipment, Gross 1.75M USD -7.1%
Operating Lease, Liability, Current 1.1M USD +38.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 263K USD -68%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.25M USD +55.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 156K USD -26.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 263K USD -68%
Deferred Tax Assets, Operating Loss Carryforwards 44.7M USD +62.9%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 69K USD -91.6%
Operating Lease, Payments 1.13M USD -12.7%
Additional Paid in Capital 594M USD +41.7%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 88K USD -12%
Share-based Payment Arrangement, Expense 19.1M USD +6.43%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%